hbips_2_measure_description,n_hbips_2_overall_rate_per_1000,n_hbips_2_overall_num,n_hbips_2_overall_den,hbips_3_measure_description,n_hbips_3_overall_rate_per_1000,n_hbips_3_overall_num,n_hbips_3_overall_den,smd_measure_description,n_smd,smd_top_10,sub_2_2a_measure_description,n_sub_2,sub_2_top_10,n_sub_2a,sub_2a_top_10,sub_3_3a_measure_description,n_sub_3,sub_3_top_10,n_sub_3a,sub_3a_top_10,tob_3_3a_measure_description,n_tob_3,tob_3_top_10,n_tob_3a,tob_3a_top_10,tr_1_measure_description,n_tr_1,tr_1_top_10,start_date,end_date,faph_measure_description,n_faph_30,faph_30_top_10,n_faph_7,faph_7_top_10,faph_measure_start_date,faph_measure_end_date,medcont_measure_description,medcont,medcont_top_10,n_medcont_measure_start_date,n_medcont_measure_end_date,readm_30_ipf_measure_desc,readm_30_ipf_national_rate,n_readm_30_ipf_ipfs_worse,n_readm_30_ipf_ipfs_same,n_readm_30_ipf_ipfs_better,n_readm_30_ipf_ipfs_too_few,readm_30_ipf_start_date,readm_30_ipf_end_date,imm_2_measure_description,n_imm_2,imm_2_top_10,flu_season_start_date,flu_season_end_date
Hours of physical-restraint use,0.31,202397.50,27630536,Hours of seclusion use,0.36,240158.57,27624247,Screening for metabolic disorders (SMD),80,100,Alcohol use brief intervention provided or offered,58,100,76,100,Alcohol and other drug use disorder treatment provided or offered at discharge,71,100,59,99,Tobacco use treatment provided or offered at discharge,57,97,16,79,Transition record with specified elements received by discharged patients (TR1),63,99,01/01/2023,12/31/2023,Percent of patients receiving follow-up care within 30 days (FAPH-30) or within 7 days (FAPH-7) after psychiatric hospitalization,59.5,76.9,35.7,53.8,07/01/2022,06/30/2023,Medication Continuation Following Inpatient Psychiatric Discharge,77.8,88.4,07/01/2021,06/30/2023,Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF),19.2,96,1269,45,137,07/01/2021,06/30/2023,Influenza immunization (IPFQR-IMM-2),76,99,10/01/2023,03/31/2024
